Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IBRUTINIB Cause Activated partial thromboplastin time prolonged? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Activated partial thromboplastin time prolonged have been filed in association with IBRUTINIB (Imbruvica). This represents 0.0% of all adverse event reports for IBRUTINIB.

5
Reports of Activated partial thromboplastin time prolonged with IBRUTINIB
0.0%
of all IBRUTINIB reports
0
Deaths
2
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From IBRUTINIB?

Of the 5 reports, 2 (40.0%) required hospitalization.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does IBRUTINIB Cause?

Death (8,007) Off label use (5,446) Fatigue (4,479) Diarrhoea (3,903) Atrial fibrillation (3,671) Pneumonia (3,015) Incorrect dose administered (2,752) Contusion (2,712) Fall (2,375) Asthenia (2,200)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Which IBRUTINIB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?

IBRUTINIB vs IBUPROFEN IBRUTINIB vs IBUPROFEN LYSINE IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT IBRUTINIB vs IBUPROFEN\IBUPROFEN IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE

Related Pages

IBRUTINIB Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged IBRUTINIB Demographics